MedTrace Logo

Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine

NCT03024229 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-23

No results posted yet for this study

Summary

When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.

Conditions

  • Renal Transplantation

Interventions

DEVICE

LifePort® perfusion machine

Renal perfusion on LifePort® machine

Sponsors & Collaborators

  • Laboratory of Biochemistry, University François Rabelais of TOURS

    collaborator UNKNOWN

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Franck BRUYERE, MD-PhD · University François Rabelais of TOURS

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2019-09-15
Completion
2020-01-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024229 on ClinicalTrials.gov